Article Information
History
- July 3, 2020.
Article Versions
- You are currently viewing Version 1 of this article (July 3, 2020 - 04:00).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Alexey Komissarov1,2,
- Ivan Molodtsov1,
- Oxana Ivanova1,2,
- Elena Maryukhnich1,2,
- Svetlana Kudryavtseva1,
- Alexey Mazus3,
- Evgeniy Nikonov4 and
- Elena Vasilieva1,2,*
- 1Clinical City Hospital named after I.V. Davydovsky, Moscow Department of Healthcare, Moscow, Russia
- 2Laboratory of Atherothrombosis, Cardiology Department, Moscow State University of Medicine and Dentistry, Moscow, Russia
- 3Moscow City Center for AIDS Prevention and Control, Moscow Department of Healthcare, Moscow, Russia
- 4Moscow Department of Healthcare, Moscow, Russia
- ↵*Correspondence to: Elena Vasilieva, MD, PhD, Clinical City Hospital named after I.V. Davydovsky, 11 Yauzskaya Street, Moscow, Russia, 109240. E-mail: vasilievahelena{at}gmail.com
Posted July 03, 2020.
Hydroxychloroquine has no effect on SARS-CoV-2 load in nasopharynx of patients with mild form of COVID-19
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos